Indication

Granuloma inguinale

Granuloma inguinale, also known as donovanosis, is a chronic, progressively destructive sexually transmitted infection caused by the intracellular bacterium *Klebsiella granulomatis* (formerly *Calymmatobacterium granulomatis*). Read more about Granuloma inguinale

223 drugs 111 manufacturers

Advertisement

Drugs that treat it

Common Granuloma inguinale therapies.

Showing 145–153 of 223 drugs

Filter & compare in the drug finder →Opens the drug finder with Granuloma inguinale preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Granuloma inguinale.

Granuloma inguinale, also known as donovanosis, is a chronic, progressively destructive sexually transmitted infection caused by the intracellular bacterium *Klebsiella granulomatis* (formerly *Calymmatobacterium granulomatis*).

The condition primarily targets sexually active adults, affecting the skin and mucous membranes of the genital, perineal, and perianal regions.

It is clinically characterized by painless, slowly expanding, beefy-red vascular ulcers with rolled, elevated borders that bleed easily upon contact and typically lack true regional lymphadenopathy.

Pathophysiologically, the organism proliferates within mononuclear phagocytes, producing distinctive intracellular inclusions termed Donovan bodies that can lead to extensive tissue destruction, secondary fibrosis, and significant genital scarring if left untreated.

Personalize your experience

Follow Granuloma inguinale and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it